Home › Funds › Deep Track Capital, LP › BCAX

Deep Track Capital, LP position in BCAX

BICARA THERAPEUTICS INC · Health Care

Deep Track Capital, LP reported holding 4,100,000 shares of BCAX (BICARA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$121.7M, representing 1.81% of its reported portfolio and ranking #24 among its reported holdings. Deep Track Capital, LP has disclosed BCAX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)4.10M sh
Reported value held$121.73M
Portfolio Weight1.81%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's BCAX position evolved

Deep Track Capital, LP first disclosed a stake in BCAX in Q3 2024 at 796,852 shares (US$20.3M). The position peaked in Q2 2026 at 4,100,000 shares, worth US$121.7M. Across 8 filings, Deep Track Capital, LP increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 4,100,000 shares valued at US$121.7M — an increase of 37,500 shares quarter over quarter.. Notable position changes include a 151% increase in Q4 2024 (shares fell 25% over the following quarter), a 55% increase in Q1 2026 (shares rose 49% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 796.85K $20.30M New
Q4 2024 2.00M $34.84M Add
Q1 2025 2.00M $26.06M Hold
Q2 2025 2.43M $22.54M Add
Q3 2025 2.43M $38.32M Hold
Q4 2025 2.61M $43.99M Add
Q1 2026 4.06M $80.80M Add
Q2 2026 4.10M $121.73M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCAX and 13F data

BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Siren, L.L.C. (US$166.4M), Vestal Point Capital, LP (US$155.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCAX

All BCAX fund holders →

FAQ

How long has Deep Track Capital, LP held BCAX?

Deep Track Capital, LP has disclosed BCAX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Deep Track Capital, LP's current position in BCAX?

As of Q2 2026, Deep Track Capital, LP holds 4.10M shares of BCAX (BICARA THERAPEUTICS INC), valued at $121.73M, representing 1.81% of its reported portfolio and ranking #24.

Has Deep Track Capital, LP been buying or selling BCAX?

In the latest 13F filing (Q2 2026), Deep Track Capital, LP increased its position in BCAX. The position peaked in Q2 2026 at 4.10M shares.

Which other funds hold BCAX?

Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Siren, L.L.C., Vestal Point Capital, LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.